Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
CompletedOBSERVATIONAL
Enrollment
3,203
Participants
Timeline
Start Date
September 10, 2013
Primary Completion Date
June 15, 2016
Study Completion Date
August 31, 2016
Conditions
DengueDengue FeverDengue Hemorrhagic Fever
Trial Locations (1)
Unknown
Ratchaburi
All Listed Sponsors
lead
Sanofi Pasteur, a Sanofi Company
INDUSTRY
NCT01983553 - Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study | Biotech Hunter | Biotech Hunter